OKYO Pharma Limited (OKYO)

OKYO Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.56	0.83	4.05	2.7	6.88
Cash & Short-Term Investments	1.56	0.83	4.05	2.7	6.88
Cash Growth	88.78%	-79.56%	49.79%	-60.73%	2807.98%
Other Receivables	1.89	0.58	0.98	0.88	0.08
Receivables	1.89	0.58	0.98	0.88	0.08
Prepaid Expenses	0.23	0.13	0.17	0.71	0.02
Total Current Assets	3.68	1.54	5.2	4.3	6.97
Property, Plant & Equipment	0	0	0.01	0.01	0.1
Total Assets	3.68	1.54	5.2	4.3	7.08
Accounts Payable	7.9	6.13	2.31	0.74	0.21
Accrued Expenses	1.24	1.19	2.65	0.61	1.46
Short-Term Debt	-	-	2.22	-	-
Current Portion of Leases	-	-	-	-	0.03
Other Current Liabilities	0.09	0.1	0.07	-	-
Total Current Liabilities	9.23	7.42	7.26	1.35	1.7
Long-Term Leases	-	-	-	-	0.06
Total Liabilities	9.23	7.42	7.26	1.35	1.77
Additional Paid-In Capital	146.72	143.11	131.39	123.98	91.91
Retained Earnings	-143.02	-142.52	-125.7	-112.43	-99.4
Comprehensive Income & Other	-9.24	-6.47	-7.74	-8.6	12.8
Shareholders' Equity	-5.55	-5.88	-2.05	2.95	5.31
Total Liabilities & Equity	3.68	1.54	5.2	4.3	7.08
Total Debt	-	-	2.22	-	0.1
Net Cash (Debt)	1.56	0.83	1.83	2.7	6.78
Net Cash Growth	88.78%	-54.82%	-32.23%	-60.16%	3211.98%
Net Cash Per Share	0.04	0.03	0.08	0.18	0.65
Filing Date Shares Outstanding	37.61	33.84	25.55	21.14	10.35
Total Common Shares Outstanding	36.02	33.34	25.52	21.14	10.35
Working Capital	-5.55	-5.88	-2.06	2.94	5.27
Book Value Per Share	-0.15	-0.18	-0.08	0.14	0.51
Tangible Book Value	-5.55	-5.88	-2.05	2.95	5.31
Tangible Book Value Per Share	-0.15	-0.18	-0.08	0.14	0.51
Machinery	0.01	0.01	0.02	0.01	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q